- Decrease font
- Increase font
- Send to a friend
Click here to bookmark this page
Customize your Bookmarks:
- Type the name of the page the way you would like it to appear in "My Bookmarks";
- Click in the "Add as My Bookmarks" button.
To choose your favorite sessions, please click here.
CCENTRO DE IMAGEM DIAGNÓSTICOS S.A. ("Company") (B3: AALR3), i(B3: AALR3), in compliance with paragraph 4 of article 157 of Law 6404/76 and Instruction 44/2021 of the Brazilian Securities and Exchange Commission ("CVM"), hereby informs its shareholders and the market in general that received, on this date, from the representative of the shareholders of the Company‘s controlling block, signatories of the shareholders‘ agreement signed on August 20, 2021, as amended (respectively, "Shareholders‘ Agreement" and "Controlling Shareholders"), notice to disclosure to the market informing that MAM ASSET MANAGEMENT GESTORA DE RECURSOS LTDA. ("MAM"), Corporate Taxpayer‘s ID (CNPJ/ME) 21.180.163/0001-73, as the manager of the investment fund Fonte de Saúde Fundo de Investimento em Participações Multiestratégia, has submitted, on this date, a binding proposal directed to the Controlling Shareholders to acquire up to the totality of the shares issued by the Company held by the Controlling Shareholders, for the price per share of R$ 20.50 (twenty reais and fifty cents), thus each Controlling Shareholder may choose the number of shares it intends to sell ("Proposal"). The Proposal is valid until November 26, 2021.
Additionally, according to the information received by the Company, the Controlling Shareholders shall meet, subject to the formalities established in their Shareholders‘ Agreement, to resolve on the Proposal within the validity period of the Proposal, that is, November 26, 2021.
The Company reiterates its commitment to keep the market informed about relevant facts and acts, in compliance with applicable regulations.
São Paulo, November 18th, 2021.
To access the full document, click here.